Nicolab is an Australian-based public unlisted company, founded in 2015 as a spin-off from Amsterdam University Medical Center. The company develops AI-powered platforms designed to diagnose acute conditions - including stroke, aortic dissection, pulmonary embolism, and incidental findings - with the goal of streamlining emergency clinical workflows and reducing treatment delays.
Its flagship product, StrokeViewer, uses medical image analysis algorithms to assist clinicians in diagnosing stroke patients. The platform has been recognised for delivering what the company describes as the most accurate stroke diagnosis algorithms available globally. Nicolab's technical work spans artificial intelligence, medical image analysis, real-time communication platforms, and clinical decision support.
The company operates across Europe, the Asia-Pacific region, and the United States, positioning its technology within the healthcare, emergency medicine, and acute conditions management sectors. Nicolab's stated mission centres on connecting human and artificial intelligence to improve patient outcomes in time-critical care settings.
